US Bancorp
NUVB icon

US Bancorp’s Nuvation Bio NUVB Stock Holding History

US Bancorp’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.02K Buy
1,588
+7
+0.4% +$34 ﹤0.01% 3486
2026
Q1 		$6.78K Buy
1,581
+106
+7% +$591 ﹤0.01% 3482
2025
Q4 		$13.2K Hold
1,475
– – ﹤0.01% 3234
2025
Q3 		$5.46K Hold
1,475
– – ﹤0.01% 3513
2025
Q2 		$2.88K Hold
1,475
– – ﹤0.01% 3789
2025
Q1 		$2.6K Sell
1,475
-1,396
-49% -$3.18K ﹤0.01% 3823
2024
Q4 		$7.64K Buy
2,871
+630
+28% +$1.62K ﹤0.01% 3515
2024
Q3 		$5.13K Hold
2,241
– – ﹤0.01% 3562
2024
Q2 		$6.54K Hold
2,241
– – ﹤0.01% 3437
2024
Q1 		$8.16K Buy
+2,241
New +$4.3K ﹤0.01% 3402
2023
Q1 		– Sell
-261
Closed -$501 – 4174
2022
Q4 		$501 Buy
+261
New +$528 ﹤0.01% 4001

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

US Bancorp's NUVB Position: Q2 2026 in Review

US Bancorp increased its Nuvation Bio (NUVB) stake by 0.44% in Q2 2026, buying an estimated $34 and bringing the position to 1,588 shares worth $9.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

US Bancorp first reported a position in NUVB in Q4 2022 and has held it in 11 quarters since. The position peaked at $13.2K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • US Bancorp held 1,588 shares of Nuvation Bio worth $9.02K as of Q2 2026.
  • US Bancorp bought 7 Nuvation Bio shares in Q2 2026, an estimated $34.
  • Nuvation Bio made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3486 holding.
  • US Bancorp first reported a position in Nuvation Bio in Q4 2022 and has held it in 11 quarters since.
  • US Bancorp's Nuvation Bio position peaked at $13.2K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.